Cargando…
Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma
PURPOSE: We aimed to determine whether the pan-immune-inflammation value (PIV) of patients with Merkel cell carcinoma (MCC) at primary diagnosis differs from controls and whether it is associated with disease stage and outcome. METHODS: In this retrospective study, we recruited MCC patients with sta...
Autores principales: | Gambichler, T., Said, S., Abu Rached, N., Scheel, C. H., Susok, L., Stranzenbach, R., Becker, J. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508022/ https://www.ncbi.nlm.nih.gov/pubmed/35098389 http://dx.doi.org/10.1007/s00432-022-03929-y |
Ejemplares similares
-
The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy
por: Susok, L., et al.
Publicado: (2022) -
Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients
por: Gambichler, Thilo, et al.
Publicado: (2022) -
Model for End-Stage Liver Disease Correlates with Disease Relapse and Death of Patients with Merkel Cell Carcinoma
por: Gambichler, Thilo, et al.
Publicado: (2023) -
Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors
por: Gambichler, T., et al.
Publicado: (2022) -
The Antineoplastic Effect of Dimethyl Fumarate on Virus-Negative Merkel Cell Carcinoma Cell Lines: Preliminary Results
por: Gambichler, Thilo, et al.
Publicado: (2023)